Fusion luciferase activity was similar in TMPRSS2(-) 293T-ACE2 cells under all four conditions and was equally less efficient than that in TMPRSS2(+) cells, suggesting that TMPRSS2 confers an advantage to the SARS-CoV-2 in fusion (and hence infection). This evidence concerns the gene TMPRSS2 and infection.